Literature DB >> 6109177

Monoamine metabolism in Down syndrome.

D M Mann, J Lincoln, P O Yates, C M Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6109177     DOI： 10.1016/s0140-6736(80)92427-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Authors:  Ahmad Salehi; J Wesson Ashford; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

2.  Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.

Authors:  Brian E Powers; Ramon Velazquez; Christy M Kelley; Jessica A Ash; Myla S Strawderman; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Brain Struct Funct       Date:  2015-12-30       Impact factor: 3.270

3.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

4.  Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  H Godridge; G P Reynolds; C Czudek; N A Calcutt; M Benton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

5.  Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.

Authors:  Jacqueline London; Claude Rouch; Linh Chi Bui; Elodie Assayag; Benoit Souchet; Fabrice Daubigney; Hind Medjaoui; Serge Luquet; Christophe Magnan; Jean Maurice Delabar; Julien Dairou; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

6.  The noradrenergic system in Alzheimer and multi-infarct dementias.

Authors:  D M Mann; P O Yates; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

7.  The effect of vasopressin treatment on learning in Down's syndrome.

Authors:  J Eisenberg; R Hamburger-Bar; R H Belmaker
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

8.  Dopamine-related oxidative stress and mitochondrial dysfunction in dopaminergic neurons differentiated from deciduous teeth-derived stem cells of children with Down syndrome.

Authors:  Xiao Sun; Hiroki Kato; Hiroshi Sato; Xu Han; Yuta Hirofuji; Takahiro A Kato; Yasunari Sakai; Shouichi Ohga; Satoshi Fukumoto; Keiji Masuda
Journal:  FASEB Bioadv       Date:  2022-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.